Xolegel Gel Barrier Therapeutics, Inc. - Treatment for Seborrheic Dermatitis
Xolegel is a topical waterless gel formulation of the antifungal agent ketoconazole, applied once-daily for the treatment of seborrheic dermatitis in immunocompetent adults and children twelve years of age and older.Posted: July 2006
Related articles
- Barrier Therapeutics Announces FDA Acceptance of its New Drug Application for Sebazole Topical Gel - December 9, 2005
Xolegel (ketoconazole) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
